1
|
Korbet SM, Genchi RM, Borok RZ and
Schwartz MM: The racial prevalence of glomerular lesions in
nephrotic adults. Am J Kidney Dis. 27:647–651. 1996. View Article : Google Scholar : PubMed/NCBI
|
2
|
Troxell ML, Saxena AB and Kambham N:
Concurrent anti-glomerular basement membrane disease and membranous
glomerulonephritis: a case report and literature review. Clin
Nephrol. 66:120–127. 2006. View
Article : Google Scholar : PubMed/NCBI
|
3
|
Whitworth JA, Morel-Maroger L, Mignon F
and Richet G: The significance of extracapillary proliferation.
Clinicpathological review of 60 patients. Nephron. 16:1–19. 1976.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Tipping PG and Timoshanko J: Contributions
of intrinsic renal cells to crescentic glomerulonephritis. Nephron
Exp Nephrol. 101:e173–e178. 2005. View Article : Google Scholar : PubMed/NCBI
|
5
|
Falk RJ and Jennette JC: Anti-neutrophil
cytoplasmic autoantibodies with specificity for myeloperoxidase in
patients with systematic vasculitis and idiopathic necrotizing and
crescentic glomerulonephritis. N Engl J Med. 318:1651–1657. 1988.
View Article : Google Scholar
|
6
|
Kamesh L, Harper L and Savage CO:
ANCA-positive vasculitis. J Am Soc Nephrol. 13:1953–1960. 2002.
View Article : Google Scholar
|
7
|
Chen M, Yu F, Zhang Y and Zhao MH:
Antineutrophil cytoplasmic autoantibody-associated vasculitis in
older patients. Medicine (Baltimore). 87:203–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Gaber LW, Wall BM and Cooke CR:
Coexistence of anti-neutrophil cytoplasmic antibody-associated
glomerulonephritis and membranous glomerulopathy. Am J Clin Pathol.
99:211–215. 1993.PubMed/NCBI
|
9
|
Taniguchi Y, Yorioka N, Kumagai J, Ito T,
Yamakido M and Taguchi T: Myeloperoxidase antineutrophil
cytoplasmic antibody-positive necrotizing crescentic
glomerulonephritis and membranous glomerulonephropathy. Clin
Nephrol. 52:253–255. 1999.
|
10
|
Kanahara K, Yorioka N, Nakamura C, Kyuden
Y, Ogata S, Taguchi T and Yamakido M:
Myeloperoxidase-antineutrophil cytoplasmic antibody-associated
glomerulonephritis with membranous nephropathy in remission. Intern
Med. 36:841–846. 1997. View Article : Google Scholar
|
11
|
Dwyer KM, Agar JW, Hill PA and Murphy BF:
Membranous nephropathy and anti-neutrophil cytoplasmic
antibody-associated glomerulonephritis: a report of 2 cases. Clin
Nephrol. 56:394–397. 2001.PubMed/NCBI
|
12
|
Tse WY, Howie AJ, Adu D, Savage CO,
Richards NT, Wheeler DC and Michael J: Association of vasculitic
glomerulonephritis with membranous nephropathy: a report of 10
cases. Nephrol Dial Transplant. 12:1017–1027. 1997. View Article : Google Scholar : PubMed/NCBI
|
13
|
Suwabe T, Ubara Y, Tagami T, Sawa N,
Hoshino J, Katori H, Takemoto F, Hara S, Aita K, Hara S and
Takaichi K: Membranous glomerulopathy induced by
myeloperoxidase-anti-neutrophil cytoplasmic antibody-related
crescentic glomerulonephritis. Intern Med. 44:853–858. 2005.
View Article : Google Scholar
|
14
|
Nasr SH, Said SM, Valeri AM, Stokes MB,
Masani NN, D’Agati VD and Markowitz GS: Membranous
glomerulonephritis with ANCA-associated necrotizing and crescentic
glomerulonephritis. Clin J Am Soc Nephrol. 4:299–308. 2009.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Shimada M, Fujita T, Nakamura N, Narita I,
Shimaya Y, Murakami R, Yamabe H, Osawa H and Okumura K: A case of
myeloperoxidase anti-neutrophil cytoplasmic antibody
(MPO-ANCA)-associated glomerulonephritis and concurrent membranous
nephropathy. BMC Nephrol. 14:732013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Hanamura K, Tojo A, Kinugasa S, Asaba K,
Onozato ML, Uozaki H, Fukayama M and Fujita T: Detection of
myeloperoxidase in membranous nephropathy-like deposits in patients
with anti-neutrophil cytoplasmic antibody-associated
glomerulonephritis. Hum Pathol. 42:649–658. 2011. View Article : Google Scholar
|
17
|
Segelmark M and Wieslander J: IgG
subclasses of antineutrophil cytoplasm autoantibodies (ANCA).
Nephrol Dial Transplant. 8:696–702. 1993.PubMed/NCBI
|